Author

Margaret M. Kolb

Observed names: Margaret Kolb, Margaret M Kolb

Observed institutions: University of North Carolina at Chapel Hill, Genentech, Huntsman Cancer Institute, UNC Lineberger Comprehensive Cancer Center, University of Pennsylvania

OpenAlex ID: A5110018016

Safety of Bevacizumab in Patients With Non–Small-Cell Lung Cancer and Brain Metastases

2009 · Mark A. Socinski, Corey J. Langer, et al. · Journal of Clinical Oncology · 240

Treatment Outcomes by Tumor Histology in Eastern Cooperative Group Study E4599 of Bevacizumab with Paclitaxel/Carboplatin for Advanced Non-small Cell Lung Cancer

2010 · Alan Sandler, Jing Yi, et al. · Journal of Thoracic Oncology · 168

Safety and Efficacy of Combining Sunitinib with Bevacizumab + Paclitaxel/Carboplatin in Non-small Cell Lung Cancer

2010 · Mark A. Socinski, Frank A. Scappaticci, et al. · Journal of Thoracic Oncology · 46

A phase III, randomized, open-label, multicenter, global study of durvalumab and bacillus calmette-guérin (BCG) versus BCG alone in high-risk, BCG-naïve non-muscle-invasive bladder cancer (NMIBC) patients (POTOMAC).

2019 · Maria De Santis, Ramil Abdrashitov, et al. · Journal of Clinical Oncology · 21

Health promotion and sport.

1995 · Margaret M Kolb · German Journal of Exercise and Sport Research · 3

Acceptable Safety of Bevacizumab Therapy in Patients with Brain Metastases as a Result of Non—Small-Cell Lung Cancer

2008 · Wallace Akerley, Corey Langer, et al. · Clinical Lung Cancer

Utilization behavior of the elderly in an HMO: A causal analysis

1988 · Margaret M Kolb · Digital Commons-TMC (Texas Medical Center)

Works count: 7

Citation count: 478

H-index: 4

I10-index: 4